An H3R antagonist acting through D1R-H3R heteromers acts as a protective agent against dopaminergic imbalance in early HD stages improving learning and long-term memory deficits and rescuing the loss of D1R-H3R complexes at late stages of HD. The gene discussed is HRH3; the disease is Huntington disease.